Gene · 708
Papers2,456
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,456
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteins from platelet-enriched preparations as candidate biomarkers for major depressive disorder: An exploratory proteomic study. | J Affect Disord | 2027 | 42826767 | PubTator, text mining | PubMed |
| Complement C1q-binding protein at the host-protozoan interface: knowns and unknowns. | Trends Parasitol | 2026 | 42481243 | PubTator, text mining | PubMed |
| 1D-2D hybrid based electrochemical sensor for nano-architected sensing of ASFV p32 - an early phosphoprotein. | Biosens Bioelectron | 2026 | 42425003 | PubTator, text mining | PubMed |
| Inhibition of Pax6 sumoylation suppresses the tumorigenicity of pancreatic cancer cells. | Cell Death Differ | 2026 | 42342900 | PubTator, text mining | PubMed |
| CHCHD2 and CHCHD10 promoted autophagic clearance of protein aggregates via GABARAPs. | Autophagy | 2026 | 42183628 | PubTator, text mining | PubMed |
| Unveiling C1QBP: A New Guardian of Dopaminergic Neuron in Parkinson's disease by targeting ULK1 to promote mitophagy and maintain mitochondrial function. | Free Radic Biol Med | 2026 | 42176906 | PubTator, text mining | PubMed |
| Enhancing immune-mediated cancer cell engulfment through biophysical techniques: an in-silico investigation focusing on the peptide-mediated disruption of a C1q-gC1qR(p33) interaction. | J Biomol Struct Dyn | 2026 | 42117492 | PubTator, text mining | PubMed |
| Polysaccharide-Rich Herbal Formula Attenuates Skin Aging and Oxidative Stress in VCD-Induced Menopause Models via Regulation of AQP-3, C1QBP, and K19. | Rejuvenation Res | 2026 | 41958012 | PubTator, text mining | PubMed |
| Spatial multiomics profiling reveals ZFP36-mediated immunometabolic reprogramming in bladder cancer. | Proc Natl Acad Sci U S A | 2026 | 41950100 | PubTator, text mining | PubMed |
| Unveiling the mysteries of C1QBP in gynecological tumors (Review). | Mol Clin Oncol | 2026 | 41929232 | PubTator, text mining | PubMed |
| Mitochondrial Long Non-Coding RNAs in Gynecological Cancers: Pathogenic Signaling Pathways and Therapeutic Opportunities. | Curr Issues Mol Biol | 2026 | 41899413 | PubTator, text mining | PubMed |
| Recombinant P32 and B5R proteins of lumpy skin disease virus as candidate antigens for serodiagnostic applications. | Vet Res Commun | 2026 | 41854938 | PubTator, text mining | PubMed |
| FBXO3-mediated DUSP9 ubiquitination promotes leukemia stem cell maintenance and tyrosine kinase inhibitor resistance in chronic myeloid leukemia. | Cell Rep Med | 2026 | 41850237 | PubTator, text mining | PubMed |
| Maternal opioid use disorder and hepatitis C infection in pregnancy reshape the peripheral immune landscape at term. | EBioMedicine | 2026 | 41849830 | PubTator, text mining | PubMed |
| Role of solute carrier family 7 member 7 in cancer: opportunities for tumor microenvironment research. | J Immunother Cancer | 2026 | 41825936 | PubTator, text mining | PubMed |
| Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) as a Biomarker of Neurodysfunction. | Neuromolecular Med | 2026 | 41820680 | PubTator, text mining | PubMed |
| Wealth, health, and happiness: An inverse story of the Easterlin Paradox in China. | PLoS One | 2026 | 41818252 | PubTator, text mining | PubMed |
| Exploring the lactate-metabolism related characteristics during the development of medulloblastoma through single-cell and bulk RNA-seq. | Transl Cancer Res | 2026 | 41815173 | PubTator, text mining | PubMed |
| Human milk oligosaccharides promote synaptogenesis and neurite outgrowth in human cortical organoids. | Biochem Biophys Rep | 2026 | 41799697 | PubTator, text mining | PubMed |
| Thrombin Generation Induced by Complement Component C1q Interaction With the Receptor for the Globular Head of C1q on Adventitial Fibroblasts and Vascular Smooth Muscle Cells. | Immun Inflamm Dis | 2026 | 41794546 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/708/papers